Literature DB >> 25963545

Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams-Oliver Syndrome With Variable Cardiac Anomalies.

Rajiv D Machado1, Richard C Trembath2,3, Laura Southgate4,2, Maja Sukalo5, Anastasios S V Karountzos1, Edward J Taylor1, Claire S Collinson4, Deborah Ruddy3, Katie M Snape6, Bruno Dallapiccola7, John L Tolmie8, Shelagh Joss8, Francesco Brancati9, M Cristina Digilio10, Luitgard M Graul-Neumann11, Leonardo Salviati12, Wiltrud Coerdt13, Emmanuel Jacquemin14,15, Wim Wuyts16, Martin Zenker5.   

Abstract

BACKGROUND: Adams-Oliver syndrome (AOS) is a rare disorder characterized by congenital limb defects and scalp cutis aplasia. In a proportion of cases, notable cardiac involvement is also apparent. Despite recent advances in the understanding of the genetic basis of AOS, for the majority of affected subjects, the underlying molecular defect remains unresolved. This study aimed to identify novel genetic determinants of AOS. METHODS AND
RESULTS: Whole-exome sequencing was performed for 12 probands, each with a clinical diagnosis of AOS. Analyses led to the identification of novel heterozygous truncating NOTCH1 mutations (c.1649dupA and c.6049_6050delTC) in 2 kindreds in which AOS was segregating as an autosomal dominant trait. Screening a cohort of 52 unrelated AOS subjects, we detected 8 additional unique NOTCH1 mutations, including 3 de novo amino acid substitutions, all within the ligand-binding domain. Congenital heart anomalies were noted in 47% (8/17) of NOTCH1-positive probands and affected family members. In leukocyte-derived RNA from subjects harboring NOTCH1 extracellular domain mutations, we observed significant reduction of NOTCH1 expression, suggesting instability and degradation of mutant mRNA transcripts by the cellular machinery. Transient transfection of mutagenized NOTCH1 missense constructs also revealed significant reduction in gene expression. Mutant NOTCH1 expression was associated with downregulation of the Notch target genes HEY1 and HES1, indicating that NOTCH1-related AOS arises through dysregulation of the Notch signaling pathway.
CONCLUSIONS: These findings highlight a key role for NOTCH1 across a range of developmental anomalies that include cardiac defects and implicate NOTCH1 haploinsufficiency as a likely molecular mechanism for this group of disorders.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Adams–Oliver syndrome; genetics; haploinsufficiency; heart defects, congenital; receptor, NOTCH1

Mesh:

Substances:

Year:  2015        PMID: 25963545      PMCID: PMC4545518          DOI: 10.1161/CIRCGENETICS.115.001086

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  43 in total

1.  O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1.

Authors:  Yuta Sakaidani; Naoki Ichiyanagi; Chika Saito; Tomoko Nomura; Makiko Ito; Yosuke Nishio; Daita Nadano; Tsukasa Matsuda; Koichi Furukawa; Tetsuya Okajima
Journal:  Biochem Biophys Res Commun       Date:  2012-01-28       Impact factor: 3.575

Review 2.  Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.

Authors:  Martin Zenker
Journal:  Curr Opin Pediatr       Date:  2011-08       Impact factor: 2.856

Review 3.  Expanding the phenotype of cardiovascular malformations in Adams-Oliver syndrome.

Authors:  Claudia Algaze; Edward D Esplin; Alexander Lowenthal; Louanne Hudgins; Theresa Ann Tacy; Elif Seda Selamet Tierney
Journal:  Am J Med Genet A       Date:  2013-04-23       Impact factor: 2.802

4.  Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies.

Authors:  Laura Southgate; Rajiv D Machado; Katie M Snape; Martin Primeau; Dimitra Dafou; Deborah M Ruddy; Peter A Branney; Malcolm Fisher; Grace J Lee; Michael A Simpson; Yi He; Teisha Y Bradshaw; Bettina Blaumeiser; William S Winship; Willie Reardon; Eamonn R Maher; David R FitzPatrick; Wim Wuyts; Martin Zenker; Nathalie Lamarche-Vane; Richard C Trembath
Journal:  Am J Hum Genet       Date:  2011-05-13       Impact factor: 11.025

5.  Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome.

Authors:  Ranad Shaheen; Eissa Faqeih; Asma Sunker; Heba Morsy; Tarfa Al-Sheddi; Hanan E Shamseldin; Nouran Adly; Mais Hashem; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2011-08-04       Impact factor: 11.025

Review 6.  The ciliopathies: a transitional model into systems biology of human genetic disease.

Authors:  Erica E Davis; Nicholas Katsanis
Journal:  Curr Opin Genet Dev       Date:  2012-05-23       Impact factor: 5.578

7.  Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.

Authors:  Joshua F Alfaro; Cheng-Xin Gong; Matthew E Monroe; Joshua T Aldrich; Therese R W Clauss; Samuel O Purvine; Zihao Wang; David G Camp; Jeffrey Shabanowitz; Pamela Stanley; Gerald W Hart; Donald F Hunt; Feng Yang; Richard D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-19       Impact factor: 11.205

8.  Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome.

Authors:  Ranad Shaheen; Mona Aglan; Kim Keppler-Noreuil; Eissa Faqeih; Shinu Ansari; Kim Horton; Adel Ashour; Maha S Zaki; Fatema Al-Zahrani; Anna M Cueto-González; Ghada Abdel-Salam; Samia Temtamy; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2013-03-21       Impact factor: 11.025

9.  RBPJ mutations identified in two families affected by Adams-Oliver syndrome.

Authors:  Susan J Hassed; Graham B Wiley; Shaofeng Wang; Ji-Yun Lee; Shibo Li; Weihong Xu; Zhizhuang J Zhao; John J Mulvihill; James Robertson; James Warner; Patrick M Gaffney
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

10.  Autosomal recessive Adams-Oliver syndrome caused by homozygous mutation in EOGT, encoding an EGF domain-specific O-GlcNAc transferase.

Authors:  Idan Cohen; Eldad Silberstein; Yonatan Perez; Daniella Landau; Khalil Elbedour; Yshaia Langer; Rotem Kadir; Michael Volodarsky; Sara Sivan; Ginat Narkis; Ohad S Birk
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

View more
  33 in total

1.  Loss of function, missense, and intronic variants in NOTCH1 confer different risks for left ventricular outflow tract obstructive heart defects in two European cohorts.

Authors:  Emmi Helle; Aldo Córdova-Palomera; Tiina Ojala; Priyanka Saha; Praneetha Potiny; Stefan Gustafsson; Erik Ingelsson; Michael Bamshad; Deborah Nickerson; Jessica X Chong; Euan Ashley; James R Priest
Journal:  Genet Epidemiol       Date:  2018-12-04       Impact factor: 2.135

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Novel missense mutation in DLL4 in a Japanese sporadic case of Adams-Oliver syndrome.

Authors:  Miwako Nagasaka; Mariko Taniguchi-Ikeda; Hidehito Inagaki; Yuya Ouchi; Daisuke Kurokawa; Keiji Yamana; Risa Harada; Kandai Nozu; Yoshitada Sakai; Sushil K Mishra; Yoshiki Yamaguchi; Ichiro Morioka; Tatsushi Toda; Hiroki Kurahashi; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2017-04-27       Impact factor: 3.172

4.  Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.

Authors:  Josephina A N Meester; Laura Southgate; Anna-Barbara Stittrich; Hanka Venselaar; Sander J A Beekmans; Nicolette den Hollander; Emilia K Bijlsma; Appolonia Helderman-van den Enden; Joke B G M Verheij; Gustavo Glusman; Jared C Roach; Anna Lehman; Millan S Patel; Bert B A de Vries; Claudia Ruivenkamp; Peter Itin; Katrina Prescott; Sheila Clarke; Richard Trembath; Martin Zenker; Maja Sukalo; Lut Van Laer; Bart Loeys; Wim Wuyts
Journal:  Am J Hum Genet       Date:  2015-08-20       Impact factor: 11.025

Review 5.  Notch Signaling and the Skeleton.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2016-04-13       Impact factor: 19.871

6.  Elucidation of radiation-resistant clones by a serial study of intratumor heterogeneity before and after stereotactic radiotherapy in lung cancer.

Authors:  Takahiro Nakagomi; Taichiro Goto; Yosuke Hirotsu; Daichi Shikata; Kenji Amemiya; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

7.  Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.

Authors:  Yusuke Watanabe; Daiki Seya; Dai Ihara; Shuhei Ishii; Taiki Uemoto; Atsushi Kubo; Yuji Arai; Yoshie Isomoto; Atsushi Nakano; Takaya Abe; Mayo Shigeta; Teruhisa Kawamura; Yoshihiko Saito; Toshihiko Ogura; Osamu Nakagawa
Journal:  J Biol Chem       Date:  2020-10-16       Impact factor: 5.157

8.  Canonical Notch Signaling Directs the Fate of Differentiating Neurocompetent Progenitors in the Mammalian Olfactory Epithelium.

Authors:  Daniel B Herrick; Zhen Guo; Woochan Jang; Nikolai Schnittke; James E Schwob
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

Review 9.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

10.  Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch.

Authors:  Beth M Harvey; Nadia A Rana; Hillary Moss; Jessica Leonardi; Hamed Jafar-Nejad; Robert S Haltiwanger
Journal:  J Biol Chem       Date:  2016-06-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.